Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-17

Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Exosomes for Parkinson's Disease [Phase 1]

View source ↗

Summary

Phase 1 trial update assessing the safety of cultured allogeneic umbilical cord-derived mesenchymal stem cell exosomes in Parkinson's disease; recruitment is on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical Cord-derived Mesenchymal Stem Cell Exosomes

Snippet

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine | Conditions: Parkinson Disease | Phase 1 | Status: RECRUITING